Silva Arslanian, ADA 2022: Lifestyle-focused interventions in young patients with type 2 diabetes and the challenges for treatment

Managing youth with type 2 diabetes has its challenges in comparison to the adult population. Dr Silva Arslanian (University of Pittsburgh, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA) discusses these challenges as well as the effectiveness of lifestyle-focused interventions in younger patients with diabetes. 

Dr Silva Arslanian presented an abstract entitled ‘Dulaglutide in Youth with Type 2 Diabetes (T2D)—Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial’ at the 82nd American Diabetes Association Scientific Session, June 3-7, 2022.

Questions: 

1. What are the current challenges in managing type 2 diabetes in younger people, compared with the adult population? (0:23)
2. How effective are lifestyle-focused interventions in the younger diabetic population? (2:03)

Disclosures: Silva Arslanian is a consultant for and has received grant/research support from Novo Nordisk and Eli Lilly. Silva Arslanian is on the advisory board for the Data Monitoring Committee at AstraZeneca.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.

Filmed as a highlight of ADA 2022.